ALPHA TRIBE

Dhampur Bio Organics LimitedPPTs, 22-01-2026: Investor Presentation

22-01-2026 | 11:13 pm

Here's a concise summary for Dhampur Bio Organics' Q3 and 9M FY26 financial results:

**Business Performance:** Q3 FY26 revenue dipped 9.36% YoY to ₹440.51 Cr due to lower sugar sales volume, though higher sugar margins boosted profitability to ₹13.87 Cr PAT. For 9M FY26, revenue grew 7.80% YoY to ₹1,529.57 Cr, despite a net loss of ₹(21.03) Cr. Non-sugar segments like Bio-Fuel & Spirits (+35.30% YoY) and Country Liquor (+29.22% YoY) showed strong revenue growth, increasing their contribution.

**Growth Drivers or Strategy:** The company is focusing on "Sugar Premiumization," shifting towards niche, processed, and value-added sugar. This includes enhancing packaged and pharma-grade sugar capacity to reduce exposure to commodity price risks and become a comprehensive sugar solutions provider.

**Recent Developments:** Long-term loans significantly reduced from ₹309 Cr (March 31, 2025) to ₹269 Cr (December 31, 2025), improving the long-term debt-to-equity ratio to 0.27x.

**Key Financial Metrics:** Q3FY26 Revenue: ₹440.51 Cr (-9.36% YoY); PAT: ₹13.87 Cr (3.15% margin). 9M FY26 Revenue: ₹1,529.57 Cr (+7.80% YoY); PAT: ₹(21.03) Cr.

**Management Commentary / Outlook:** Management aims to further diversify revenue streams, leveraging the more stable margins from non-sugar businesses for sustainable growth.

No comments yet. Be the first to comment!

All announcements from Dhampur Bio Organics Limited